American biosimulation and regulatory science company headquartered in Radnor, Pennsylvania, formed in 2008 from the combination of Simcyp, Tripos and Pharsight and listed on Nasdaq since 2020. Provides physiologically based pharmacokinetic modelling with the Simcyp simulator, pharmacometric software including Phoenix WinNonlin, quantitative systems pharmacology, model informed drug development consulting, regulatory writing and submission services and real world evidence and market access analytics for pharmaceutical and biotechnology clients and regulators.
Aucun commentaire disponible.
Laissez votre note & commentaire